instruction stringlengths 35 191 | input stringlengths 0 31.3k | output stringlengths 0 1.83k |
|---|---|---|
Do Abaloparatide and Acebutolol interact with each other? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
Rate the interaction severity between Abaloparatide and Acebutolol. | Minor | |
Can Abaloparatide and Aldesleukin be taken together? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
How severe is the interaction between Abaloparatide and Aldesleukin? | Minor | |
How do Abaloparatide and Aliskiren interact? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
Rate the interaction severity between Abaloparatide and Aliskiren. | Minor | |
Do Abaloparatide and Ambrisentan interact with each other? | The use of two drugs that both lower blood pressure may result in a more pronounced hypotensive effect. | |
How severe is the interaction between Abaloparatide and Ambrisentan? | Minor | |
How do Abaloparatide and Amifostine interact? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. |
What is the risk level of combining Abaloparatide and Amifostine? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
Is there an interaction between Abaloparatide and Amiloride? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
Rate the interaction severity between Abaloparatide and Amiloride. | Minor | |
Do Abaloparatide and Amiodarone interact with each other? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
Rate the interaction severity between Abaloparatide and Amiodarone. | Minor | |
Can Abaloparatide and Amlodipine be taken together? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
Rate the interaction severity between Abaloparatide and Amlodipine. | Minor | |
How do Abaloparatide and Amobarbital interact? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | The use of barbiturates may increase hypotension. 1,2 Therefore, the concomitant administration of barbiturates and hypotensive agents may lead to dangerous hypotension due to additive effects. |
Rate the interaction severity between Abaloparatide and Amobarbital. | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Moderate |
Is there an interaction between Abaloparatide and Amphotericin B? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
What is the risk level of combining Abaloparatide and Amphotericin B? | Minor | |
Is there an interaction between Abaloparatide and Amyl Nitrite? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
How severe is the interaction between Abaloparatide and Amyl Nitrite? | Minor | |
Can Abaloparatide and Apomorphine be taken together? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
What is the severity of the interaction when Abaloparatide and Apomorphine are co-administered? | Minor | |
Do Abaloparatide and Aripiprazole lauroxil interact with each other? | Aripiprazole may cause orthostatic hypotension through antagonism of the α1-adrenergic receptor. 3,2,4 Cases of orthostatic hypotension, postural dizziness, and syncope have been reported with the short-term use of aripiprazole in clinical trials. The risk for developing a decrease in blood pressure may be enhanced wit... | |
What is the risk level of combining Abaloparatide and Aripiprazole lauroxil? | Minor | |
How do Abaloparatide and Aripiprazole interact? | Aripiprazole may cause orthostatic hypotension through antagonism of the α1-adrenergic receptor. 3,2,4 Cases of orthostatic hypotension, postural dizziness, and syncope have been reported with the short-term use of aripiprazole in clinical trials. The risk for developing a decrease in blood pressure may be enhanced wit... | |
Rate the interaction severity between Abaloparatide and Aripiprazole. | Minor | |
Do Abaloparatide and Arsenic trioxide interact with each other? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
Rate the interaction severity between Abaloparatide and Arsenic trioxide. | Minor | |
Do Abaloparatide and Atenolol interact with each other? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. |
Rate the interaction severity between Abaloparatide and Atenolol. | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
Do Abaloparatide and Avanafil interact with each other? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | The subject drug is a phosphodiesterase 5 inhibitor which can lower blood pressure. 1 The affected drug can cause hypotension, particularly orthostatic hypotension. Concomitant administration of these medications may lead to an increased risk of hypotension and orthostatic hypotension. |
How severe is the interaction between Abaloparatide and Avanafil? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
How do Abaloparatide and Azilsartan medoxomil interact? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. |
Rate the interaction severity between Abaloparatide and Azilsartan medoxomil. | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
How do Abaloparatide and Benazepril interact? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
What is the risk level of combining Abaloparatide and Benazepril? | Minor | |
How do Abaloparatide and Betaxolol interact? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
Rate the interaction severity between Abaloparatide and Betaxolol. | Minor | |
Is there an interaction between Abaloparatide and Bisoprolol? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. |
What is the risk level of combining Abaloparatide and Bisoprolol? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
Is there an interaction between Abaloparatide and Bosentan? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | The use of two drugs that both lower blood pressure may result in a more pronounced hypotensive effect. |
How severe is the interaction between Abaloparatide and Bosentan? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
Is there an interaction between Abaloparatide and Bretylium? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
What is the risk level of combining Abaloparatide and Bretylium? | Minor | |
Is there an interaction between Abaloparatide and Bromocriptine? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. |
How severe is the interaction between Abaloparatide and Bromocriptine? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
Can Abaloparatide and Bumetanide be taken together? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
Rate the interaction severity between Abaloparatide and Bumetanide. | Minor | |
Can Abaloparatide and Bupivacaine be taken together? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. |
Rate the interaction severity between Abaloparatide and Bupivacaine. | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
Do Abaloparatide and Canagliflozin interact with each other? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
What is the severity of the interaction when Abaloparatide and Canagliflozin are co-administered? | Minor | |
Is there an interaction between Abaloparatide and Candesartan cilexetil? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. |
What is the risk level of combining Abaloparatide and Candesartan cilexetil? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
Is there an interaction between Abaloparatide and Captopril? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
What is the severity of the interaction when Abaloparatide and Captopril are co-administered? | Minor | |
Can Abaloparatide and Carbetocin be taken together? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
Rate the interaction severity between Abaloparatide and Carbetocin. | Minor | |
Is there an interaction between Abaloparatide and Carvedilol? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
Rate the interaction severity between Abaloparatide and Carvedilol. | Minor | |
How do Abaloparatide and Celiprolol interact? | The use of two drugs that both lower blood pressure may result in a more pronounced hypotensive effect. | |
Rate the interaction severity between Abaloparatide and Celiprolol. | Minor | |
Do Abaloparatide and Chlorothiazide interact with each other? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. |
How severe is the interaction between Abaloparatide and Chlorothiazide? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
Do Abaloparatide and Chlorpromazine interact with each other? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
Rate the interaction severity between Abaloparatide and Chlorpromazine. | Minor | |
Is there an interaction between Abaloparatide and Chlorthalidone? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. |
Rate the interaction severity between Abaloparatide and Chlorthalidone. | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
Is there an interaction between Abaloparatide and Cilazapril? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. |
What is the risk level of combining Abaloparatide and Cilazapril? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
Is there an interaction between Abaloparatide and Clevidipine? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
What is the severity of the interaction when Abaloparatide and Clevidipine are co-administered? | Minor | |
Do Abaloparatide and Clofarabine interact with each other? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. |
What is the risk level of combining Abaloparatide and Clofarabine? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
Do Abaloparatide and Clomipramine interact with each other? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
How severe is the interaction between Abaloparatide and Clomipramine? | Minor | |
Do Abaloparatide and Clonidine interact with each other? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
What is the risk level of combining Abaloparatide and Clonidine? | Minor | |
How do Abaloparatide and Clozapine interact? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
How severe is the interaction between Abaloparatide and Clozapine? | Minor | |
How do Abaloparatide and Conivaptan interact? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. |
How severe is the interaction between Abaloparatide and Conivaptan? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
How do Abaloparatide and Dapagliflozin interact? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. |
What is the risk level of combining Abaloparatide and Dapagliflozin? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
Do Abaloparatide and Dasiglucagon interact with each other? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | The use of two drugs that both lower blood pressure may result in a more pronounced hypotensive effect. |
What is the severity of the interaction when Abaloparatide and Dasiglucagon are co-administered? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
How do Abaloparatide and Desflurane interact? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
Rate the interaction severity between Abaloparatide and Desflurane. | Minor | |
Can Abaloparatide and Dexmedetomidine be taken together? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
How severe is the interaction between Abaloparatide and Dexmedetomidine? | Minor | |
Can Abaloparatide and Diazoxide be taken together? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
What is the risk level of combining Abaloparatide and Diazoxide? | Minor | |
Is there an interaction between Abaloparatide and Diclofenamide? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. |
Rate the interaction severity between Abaloparatide and Diclofenamide. | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
Is there an interaction between Abaloparatide and Digoxin? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Cases of clinical toxicity have been documented with digoxin levels in the therapeutic range. 2 Some studies report that electrolyte imbalances, such as hypercalcemia, can alter the effects of digoxin on the myocardium and increase sensitivity to digoxin, elevating the risk for digoxin toxicity even with a lower serum ... |
What is the risk level of combining Abaloparatide and Digoxin? | Indication (Drug A): Abaloparatide is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture (defined as a history of osteoporotic fracture or multiple risk factors for fracture) or patients who have failed or are intolerant to other available osteoporosis therapy. In postmenopa... | Minor |
Do Abaloparatide and Diltiazem interact with each other? | Co-administration of agents that are both associated with a risk for developing hypotension, including cases of severe hypotension, may create an additive hypotensive effect to prolong and intensify hypotensive effects. | |
How severe is the interaction between Abaloparatide and Diltiazem? | Minor |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.